Pharmaceutical formulators often face considerable challenges in maintaining the stability and bioavailability of acid-sensitive active pharmaceutical ingredients (APIs), such as peptides, proteins, and live biotherapeutics.
From sensing to imaging, and sampling to delivery, smart capsules have a key role to play in treating gastrointestinal disorders. In this briefing paper, we summarize the key findings from the GENEGUT review – exploring the latest capabilities and future developments of this exciting technology.
Watch Dr. Camille Dumont and Meeta Kratz's presentation at CPHI Worldwide 2024. Explore Lonza’s Innovaform® new innovation center, dedicated to accelerating...